NEWS

IMMONC at the ASCO 2024 Annual Meeting

Update on the “Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone. Can This Modality Improve the Antiemetic Effect” trial

Astghik Voskanyan presented recent developments of the BPDCN International Registry at the 29th Congress of EHA

OncoDaily Leukemia Conference

OncoThon 2024

IMMONC Team at AOC 2024

CLINICAL TRIAL APPROVAL GRANTED

Amalya Sargsyan has been awarded the ASCO IDEA Award

CLINICAL TRIAL UPDATE

IMMONC annual report for 2023

Amalya Sargsyan was granted an ESO Fellowship in Milan

Introducing our Research Fellow, Dr. Lusine Harutyunyan

Moffitt Cancer Center joins BPDCN International Registry

IMMONC Research Fellowship Program-Armenia

BPDCN Updates and Progress in 2023 – Naveen Pemmaraju

The Children’s Welfare Teaching Hospital, University of Baghdad joins BPDCN international registry